Overview
Viatris, based in Canonsburg, Pennsylvania, provides medicines across cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology and women’s health, and reports through Developed Markets, Greater China, JANZ (Japan, Australia and New Zealand) and Emerging Markets segments.[2] Forbes records its founding in November 2020, making it the youngest company in the list.[2] Sales were US$14.6bn, 0.7% lower than the prior-year figure, and the company reported a loss of US$296.5m.[2] It slipped one place to twenty-second, behind Regeneron. Its market value of US$19.2bn is the lowest in the ranking. Forbes counts 32,000 employees.[2]
Viatris strengths and limitations
Strengths
- Wide geographic footprint
- Large established-brands portfolio
- Broad therapeutic coverage
Limitations
- Net loss on Forbes figures
- Sales declining
- Low market value relative to sales
Appears in
Viatris peers and competitors
Companies ranked in the same lists as Viatris.
Johnson & Johnson- Amgen
Daiichi Sankyo- Astellas Pharma
- Regeneron Pharmaceuticals
- CSL
Otsuka Holdings- Teva Pharmaceutical
Merck KGaA
Gilead Sciences
Takeda Pharmaceutical
GSK plc
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.